Related Experiment Video
Updated: Feb 6, 2026

De Novo Generation of Somatic Stem Cells by YAP/TAZ
Published on: May 7, 2018
A feed forward loop enforces YAP/TAZ signaling during tumorigenesis
Mandeep K Gill1,2, Tania Christova1,2, Ying Y Zhang3,4
1Department of Biochemistry, University of Toronto, Toronto, ON, M5S 1A8, Canada.
Abstract:
In most solid tumors, the Hippo pathway is inactivated through poorly understood mechanisms that result in the activation of the transcriptional regulators, YAP and TAZ. Here, we identify NUAK2 as a YAP/TAZ activator that directly inhibits LATS-mediated phosphorylation of YAP/TAZ and show that NUAK2 induction by YAP/TAZ and AP-1 is required for robust YAP/TAZ signaling. Pharmacological inhibition or loss of NUAK2 reduces the growth of cultured cancer cells and mammary tumors in mice. Moreover, in human patient samples, we show that NUAK2 expression is elevated in aggressive, high-grade bladder cancer and strongly correlates with a YAP/TAZ gene signature. These findings identify a positive feed forward loop in the Hippo pathway that establishes a key role for NUAK2 in enforcing the tumor-promoting activities of YAP/TAZ. Our results thus introduce a new opportunity for cancer therapeutics by delineating NUAK2 as a potential target for re-engaging the Hippo pathway.
Insights
Researchers discovered NUAK2 activates YAP/TAZ signaling, promoting cancer growth. Inhibiting NUAK2 slowed tumor growth in mice, suggesting NUAK2 as a potential cancer therapeutic target for reactivating the Hippo pathway.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- The Hippo pathway regulates organ size and is often inactivated in solid tumors.
- Yeast and TAZ (transcriptional co-activators) are key downstream effectors of the Hippo pathway.
- Mechanisms of Hippo pathway inactivation and YAP/TAZ activation in cancer are not fully understood.
Purpose of the Study:
- To identify novel regulators of YAP/TAZ activity in cancer.
- To investigate the role of NUAK2 in Hippo pathway signaling and tumor progression.
- To explore NUAK2 as a potential therapeutic target for YAP/TAZ-driven cancers.
Main Methods:
- Investigated NUAK2's interaction with YAP/TAZ and LATS kinase.
- Assessed the impact of NUAK2 inhibition on cancer cell growth and mammary tumor development in mouse models.
- Analyzed NUAK2 expression and its correlation with YAP/TAZ signatures in human bladder cancer patient samples.
Main Results:
- NUAK2 was identified as a direct activator of YAP/TAZ by inhibiting LATS-mediated phosphorylation.
- NUAK2 expression is induced by YAP/TAZ and AP-1, forming a positive feedback loop.
- Pharmacological inhibition or genetic loss of NUAK2 suppressed cancer cell proliferation and mammary tumor growth in vivo.
- Elevated NUAK2 expression in aggressive bladder cancer correlated strongly with YAP/TAZ gene signatures.
Conclusions:
- NUAK2 plays a critical role in sustaining YAP/TAZ signaling and promoting tumor growth.
- A positive feedback loop involving NUAK2, YAP/TAZ, and AP-1 reinforces oncogenic signaling.
- NUAK2 represents a promising therapeutic target for reactivating the Hippo pathway in YAP/TAZ-driven cancers.
Related Concept Videos
Cell Signaling Feedback Loops
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
Feedback Loops
Open and closed-loop control systems
An open-loop control system operates without feedback from the output. It consists of two primary elements: the controller and the controlled process. The controller receives an input signal...
Positive and Negative Feedback Loops
Endocrine Signaling
Bacterial Signaling

